Both CD4+ FoxP3+ and CD4+ FoxP3- T cells from patients with B-cell malignancy express cytolytic markers and kill autologous leukaemic B cells in vitro.

Source:http://linkedlifedata.com/resource/pubmed/id/21463298

Download in:

View as

General Info

PMID
21463298